Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	32.77B
Revenue (ttm)	8.94B
Net Income (ttm)	779.90M
Shares Out	1.49B
EPS (ttm)	0.53
PE Ratio	41.34
Forward PE	19.12
Dividend	0.25 (1.14%)
Ex-Dividend Date	Jul 10, 2025

Volume	46,517,194
Average Volume	54,708,461
Open	21.56
Previous Close	21.99
Day's Range	20.75 - 21.74
52-Week Range	13.49 - 27.97
Beta	0.35
RSI	38.05
Earnings Date	Oct 30, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 9,065
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2024, SHA:600521's revenue was 9.55 billion, an increase of 14.91% compared to the previous year's 8.31 billion. Earnings were 1.12 billion, an increase of 34.74%.